Journey Medical Corporation
DERM
$6.99
-$0.36-4.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.99% | 170.98% | -114.24% | 59.81% | -3.02% |
| Total Depreciation and Amortization | 29.90% | 21.60% | 0.12% | -23.03% | -23.37% |
| Total Amortization of Deferred Charges | 62.90% | 4,600.00% | 50.00% | -77.06% | 264.71% |
| Total Other Non-Cash Items | 7.51% | 107.50% | 81.62% | -59.93% | 62.30% |
| Change in Net Operating Assets | -147.03% | 90.67% | -313.38% | -170.67% | -56.78% |
| Cash from Operations | 43.57% | 113.47% | -106.17% | -230.41% | -425.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -66.33% | -- | -- | -- |
| Total Debt Repaid | -- | -- | 94.32% | -- | -- |
| Issuance of Common Stock | 157.91% | 36.03% | 1,631.82% | 933.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 86.84% | -- | -- | -- |
| Cash from Financing | 119.73% | -44.72% | 97.32% | 138.44% | 3,048.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.62% | -180.15% | -118.68% | 98.41% | 42.72% |